Tourmaline Bio, Inc.
TRML
$13.12
-$0.28-2.09%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 258.30M | 281.92M | 289.53M | 293.06M | 202.95M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.54M | 11.86M | 8.59M | 7.04M | 5.92M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 268.84M | 293.79M | 298.13M | 300.10M | 208.87M |
|
|
|||||
| Total Current Assets | 268.84M | 293.79M | 298.13M | 300.10M | 208.87M |
| Net Property, Plant & Equipment | 267.00K | 307.00K | 355.00K | 402.00K | 447.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.26M | 1.89M | 1.43M | 1.43M | 974.00K |
| Total Assets | 309.00M | 328.45M | 344.79M | 359.17M | 210.30M |
|
|
|||||
| Total Accounts Payable | 3.58M | 2.05M | 2.39M | 1.94M | 1.07M |
| Total Accrued Expenses | 5.10M | 5.00M | 3.75M | 2.67M | 3.71M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 227.00K | 226.00K | 224.00K | 223.00K | 221.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 8.91M | 7.28M | 6.36M | 4.83M | 5.00M |
|
|
|||||
| Total Current Liabilities | 8.91M | 7.28M | 6.36M | 4.83M | 5.00M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 17.00K | 64.00K | 109.00K | 153.00K | 194.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 23.00K | 31.00K | 39.00K | 50.00K | 57.00K |
| Total Liabilities | 8.95M | 7.38M | 6.51M | 5.03M | 5.25M |
|
|
|||||
| Common Stock & APIC | 435.02M | 433.27M | 431.58M | 429.75M | 267.03M |
| Retained Earnings | -135.26M | -113.03M | -92.85M | -75.36M | -62.05M |
| Treasury Stock & Other | 296.00K | 821.00K | -452.00K | -253.00K | 67.00K |
| Total Common Equity | 300.05M | 321.07M | 338.28M | 354.14M | 205.04M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 300.05M | 321.07M | 338.28M | 354.14M | 205.04M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 300.05M | 321.07M | 338.28M | 354.14M | 205.04M |
|
|
|||||
